SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1 | -66.7% | 2,886 | -6.5% | 0.00% | – |
Q4 2022 | $3 | -100.0% | 3,086 | -77.9% | 0.00% | – |
Q3 2022 | $22,000 | -21.4% | 13,986 | 0.0% | 0.00% | – |
Q2 2022 | $28,000 | -89.7% | 13,986 | -88.0% | 0.00% | -100.0% |
Q1 2022 | $271,000 | +2363.6% | 116,290 | +3534.1% | 0.00% | – |
Q4 2021 | $11,000 | -99.4% | 3,200 | -98.8% | 0.00% | -100.0% |
Q3 2021 | $1,972,000 | -21.2% | 258,450 | 0.0% | 0.01% | -25.0% |
Q2 2021 | $2,504,000 | +3477.1% | 258,450 | +2958.6% | 0.02% | – |
Q1 2021 | $70,000 | +11.1% | 8,450 | -8.2% | 0.00% | – |
Q4 2020 | $63,000 | -68.7% | 9,200 | -49.0% | 0.00% | -100.0% |
Q3 2020 | $201,000 | +1727.3% | 18,050 | +961.8% | 0.00% | – |
Q2 2020 | $11,000 | +266.7% | 1,700 | -7.6% | 0.00% | – |
Q1 2020 | $3,000 | – | 1,840 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
Aristides Capital LLC | 24,302 | $271,000 | 0.19% |